Pirfenidone, initially indicated for lung fibrosis, has gone beyond its original purpose, and
shown promise in eye care. This detailed review tracks its evolution from lung treatment to …

Ophthalmic diseases can result in permanent vision loss and blindness. Convenient topical
and systemic treatments are preferred to address these sight-threatening conditions …

Aim: The fixed-dose combination of moxifloxacin (MOXI) and ketorolac tromethamine (KTR)
is widely used for the treatment of bacterial keratitis. Thus, a new LC–MS/MS method was …

Unforeseen surfacing of microbial keratitis (MKT) over the years has led to a requisite for
promising treatment strategy involving combination of antifungal and antibacterial agents …

Ocular disorders can lead to serious sight impairment and irreversible blindness. Generally
simple topical and systemic treatments are recommended for treating these vision …

Ocular drug delivery is constrained by anatomical and physiological barriers, necessitating
innovative solutions for effective therapy. Natural polymers like hyaluronic acid, chitosan …

Amid the escalating prevalence of eye diseases and the intricate nature of the eye as a
crucial target organ for drug delivery, researchers face significant challenges in developing …

Introduction Research on nanotechnology in medicine has also involved the ocular field and
nanomicelles are among the applications developed. This approach is used to increase …

Current ocular medication delivery technologies struggle with insufficient drug
bioavailability. Drug nanocarriers with inherent bioadhesion and corneal retention abilities …

Ocular drug delivery systems play a critical role in the treatment of various eye diseases via
ensuring targeted and efficient delivery of therapeutic agent. The complex anatomy and …